Source link : https://www.newshealth.biz/health-news/arn-inhibitor-reduces-major-cv-events-in-ami/
TOPLINE: In patients with heart failure (HF) due to acute myocardial infarction (AMI), angiotensin receptor–neprilysin (ARN) inhibitors lower the risk for cardiovascular (CV) events, reduce HF rehospitalizations, and improve cardiac remodeling. METHODOLOGY: A meta-analysis of nine studies (eight randomized controlled trials and one echo substudy) conducted until February 2024 included 6597 patients with AMI and […]
Author : News Health
Publish date : 2024-12-16 10:28:20
Copyright for syndicated content belongs to the linked Source.